Title: The Future of Electroanalgesia: Emerging Technologies and Trends – A Look at Quantum Re-Generation
In the realm of innovative and unique technologies, Quantum Re-Generation stands out as a groundbreaking solution in the field of pain management. This technology is capable of treating pain and acting on a muscular level with decontraction action. This is achieved through the emission of high-tension depolarizing microcurrents.
Quantum Re-Generation has a therapeutic effect on both acute chronic and post-traumatic pain. It also exhibits therapeutic anti-inflammatory and decontraction properties. Its action is based on the Gate Control Theory, allowing for the inhibition of nociceptive afferent transmission that occurs through small-diameter fibers. This is achieved through the use of pulsed microcurrents with a time interval of a millionth of a second per impulse, acting on muscle tissue and exhibiting decontraction while increasing tissue oxygenation.
The technology applies a procedure of electro-analgesia and neuro-modulation. In general, the ultimate goal of any analgesia technique is always to inhibit the transmission of the pain impulse using an electric stimulus. The Re-Generation device features interchangeable tip attachments for treating small, localized areas such as the temporomandibular joint or larger areas like the treatment of peripheral nerve canal syndromes such as the Sciatic Nerve.
Quantum Re-Generation works by using high-tension depolarizing microcurrents to act on C-fiber receptors (specialized neurons that transmit pain sensations slowly and deeply) to provide a ‘counter-information’. The analgesic effect is immediate. Just as chronic pain remodels neural circuits and creates ‘vicious circles’ that amplify suffering, repeated application of this therapy with a complete cycle of multiple sessions can, in turn, remodel these altered sensory circuits, allowing for a reduction in hyper-sensitivity to pain.
To date, Quantum Re-Generation has been widely tested on patients with various painful musculoskeletal symptoms, neuropathic pain, and even oncological pain in different pathologies:
Quantum Re-Generation has proven extremely useful after just the first application on patients with sub-acromial conflict syndrome and supra-spinous tendon pain, as well as rotator cuff tendinitis.
It has shown effective in inhibiting the pain caused by plantar fasciitis generated by calcaneal spurs.
It has been tested with positive results on patients with degenerative joint arthrosis with pain and functional limitation. All cervical, dorsal, lumbar, and sacro-coccygeal back pain has been treated. It has shown very positive results on rheumatoid arthritis and arthrosis of the hand, showing a clear reduction in pain with an increase in hand function.
Patients with chronic pain present for more than six months and acute pain from recent trauma, such as distortive ankle trauma, have also shown positive results. Positive results have also been obtained in the treatment of issues related to ligamentous and muscular problems such as iliotibial band syndrome with pain and limitation of mobility.
The technology has been tested on patients with temporomandibular joint dysfunction, pain at the level of the masticatory muscles due to Bruxism and pain at the joint. In this type of patient, a clear reduction in pain and a reduction in muscle hypertonia that generated Bruxism, both concentric and eccentric, have been observed.
The device has been used in a case of neurological rigidity due to Motor Neuron Disease, Sclerosis Laterale Amiotrofica. The patient showed a clear reduction in muscle hypertonia with a significant improvement in walking.
Quantum Re-Generation has been used as an analgesic therapy in the management of non-opioid-responsive oncological pain, showing significant reductions in perceived pain levels. The treatment has been focused on painful bone metastases after Radiotherapy. The device has also been used in the veterinary field. Specifically, dogs with degenerative joint arthrosis in their limbs have been treated. Already from the first treatment, the dog has improved its global mobility, indicating a clear reduction in pain. The joint range of motion and walking on all four limbs with complete weight distribution have improved.
The device has been well tolerated and accepted by all patients. No side effects of any kind have been observed, and all treated patients have shown a significant reduction in pain.
